BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 3.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $516,000 | -34.5% | 400,000 | -46.7% | 0.04% | -64.8% |
| Q3 2019 | $788,000 | -73.0% | 750,000 | +200.0% | 0.12% | -75.4% |
| Q2 2017 | $2,920,000 | +18.3% | 250,000 | +25.0% | 0.50% | +2.9% |
| Q1 2017 | $2,468,000 | -47.4% | 200,000 | -13.6% | 0.48% | -29.8% |
| Q4 2015 | $4,693,000 | +39.5% | 231,515 | +0.0% | 0.69% | +60.1% |
| Q3 2015 | $3,364,000 | -31.7% | 231,514 | 0.0% | 0.43% | -11.0% |
| Q2 2015 | $4,924,000 | -13.5% | 231,514 | -7.2% | 0.48% | -18.7% |
| Q1 2015 | $5,693,000 | – | 249,567 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |